Clario Medical Imaging, Inc.

Clario Medical Imaging, Inc. provides innovative imaging solutions aimed at enhancing the efficiency of radiology departments and healthcare workflows, utilizing advanced AI technology for better patient care. Clario Medical Imaging, Inc. specializes in imaging solutions that streamline radiology workflows.

Founded in 2005 and headquartered in Seattle, US, the company has undergone a business pivot with an acquisition by Intelerad Medical Systems Incorporated in November 2018. The company is led by CEO Chris Wood, who has a background in medical imaging startups. Clario has successfully raised a total of USD 0. 74 mn, with its latest funding round on November 25, 2018, backed by West River Group.

This round is also the total amount raised to date. Clario Medical Imaging, Inc. offers a cloud-native and AI-driven imaging workflow management platform designed to improve the operational efficiency of radiology departments. This platform ensures timely delivery of the right imaging studies to specialists, thereby reducing administrative burdens and enhancing patient care.

It is integrated into various healthcare environments across North America, Europe, Australia, and Asia, serving hospitals and radiology practices where end users, including radiologists and healthcare professionals, benefit from optimized workflow efficiencies. Clario Medical Imaging, Inc. generates revenue through a subscription-based model that provides access to its imaging solutions, including the core product, InteleOrchestrator, as well as IntelePACS and InteleGence. Clients, typically healthcare institutions, subscribe according to their specific needs with scalable agreements based on usage and the number of users.

This B2B model allows for flexible deployment options, including cloud-based solutions suitable for a range of healthcare providers, from independent practices to large systems. Clario Medical Imaging, Inc. plans to enhance its product offerings and expand its market reach. Following the acquisition by Intelerad Medical Systems, there are intentions to launch new products designed to further streamline radiology processes.

Specific regions targeted for expansion are not disclosed; however, the company aims to leverage recent funding of USD 0. 74 mn to support these initiatives and capitalize on emerging markets. The focus will likely be on expanding its footprint in existing territories and enhancing product capabilities by integrating further advanced AI technologies.